Oxaphosphinanes: New therapeutic perspectives for glioblastoma

Journal of Medicinal Chemistry

Volumn 55, Issue 5, 2012, Pages 2196-2211

  Clarion, Ludovic ^a,b   Jacquard, Carine ^a   Sainte Catherine, Odile ^c   Loiseau, Séverine ^b   Filippini, Damien ^b   Hirlemann, Marie Hélène ^b   Volle, Jean Noël ^b   Virieux, David ^b   Lecouvey, Marc ^c   Pirat, Jean Luc ^b   Bakalara, Norbert ^a  

^a Montpellier University Medical Center   (France)

^b INSTITUT CHARLES GERHARDT   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(SPSSSR) 3 HYDROXY 4,5 BIS BENZYLOXY 6 BENZYLOXYMETHYL 2 PHENYL 2 OXO 2 5 [1,2]OXAPHOSPHINANE; ANTINEOPLASTIC AGENT; PACLITAXEL; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG SYNTHESIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; NATIONAL HEALTH ORGANIZATION; PHYLOGENY; STEREOCHEMISTRY;

ANIMALS; ANTINEOPLASTIC AGENTS; ASTROCYTES; BRAIN NEOPLASMS; CELL COUNT; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIC P-OXIDES; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOBLASTOMA; HUMANS; PHOSPHONIC ACIDS; RATS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84858030387     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201428a     Document Type: Article

References (37)

1. Bauchet, L.; Mathieu-Daude, H.; Fabbro-Peray, P.; Rigau, V.; Fabbro, M.; Chinot, O.; Pallusseau, L.; Carnin, C.; Laine, K.; Schlama, A.; Thiebaut, A.; Patru, M. C.; Bauchet, F.; Lionnet, M.; Wager, M.; Faillot, T.; Taillandier, L.; Figarella-Branger, D.; Capelle, L.; Loiseau, H.; Frappaz, D.; Campello, C.; Kerr, C.; Duffau, H.; Reme-Saumon, M.; Tretarre, B.; Daures, J. P.; Henin, D.; Labrousse, F.; Menei, P.; Honnorat, J. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004 Neuro-Oncology 2010, 12, 725-735
2. Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma CA Cancer J. Clin. 2010, 60, 166-193
3. Gerstner, E. R.; Chen, P. J.; Wen, P. Y.; Jain, R. K.; Batchelor, T. T.; Sorensen, G. Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib Neuro-Oncology 2010, 12, 466-472
4. Fraum, T. J.; Kreisl, T. N.; Sul, J.; Fine, H. A.; Iwamoto, F. M. Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy J. Neurooncol. 2011, 105, 287-289
5. Uhm, J. H.; Ballman, K. V.; Wu, W.; Giannini, C.; Krauss, J. C.; Buckner, J. C.; James, C. D.; Scheithauer, B. W.; Behrens, R. J.; Flynn, P. J.; Schaefer, P. L.; Dakhill, S. R.; Jaeckle, K. A. Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074 Int. J. Radiat. Oncol. Biol. Phys. 2011, 80, 347-353
6. Neyns, B.; Sadones, J.; Joosens, E.; Bouttens, F.; Verbeke, L.; Baurain, J. F.; D'Hondt, L.; Strauven, T.; Chaskis, C.; In't Veld, P.; Michotte, A.; De Greve, J. Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma Ann. Oncol. 2009, 20, 1596-1603
7. Brada, M.; Stenning, S.; Gabe, R.; Thompson, L. C.; Levy, D.; Rampling, R.; Erridge, S.; Saran, F.; Gattamaneni, R.; Hopkins, K.; Beall, S.; Collins, V. P.; Lee, S. M. Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma J. Clin. Oncol. 2010, 28, 4601-4608
8. Westphal, M.; Hilt, D. C.; Bortey, E.; Delavault, P.; Olivares, R.; Warnke, P. C.; Whittle, I. R.; Jaaskelainen, J.; Ram, Z. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology 2003, 5, 79-88
9. Sabbah, P.; Foehrenbach, H.; Dutertre, G.; Nioche, C.; DeDreuille, O.; Bellegou, N.; Mangin, J. F.; Leveque, C.; Faillot, T.; Gaillard, J. F.; Desgeorges, M.; Cordoliani, Y. S. Multimodal anatomic, functional, and metabolic brain imaging for tumor resection Clin. Imaging 2002, 26, 6-12
10. Stummer, W.; Pichlmeier, U.; Meinel, T.; Wiestler, O. D.; Zanella, F.; Reulen, H. J. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol. 2006, 7, 392-401
11. Volle, J.-N.; Filippini, D.; Krawczyk, B.; Kaloyanov, N.; Van der Lee, A.; Maurice, T.; Pirat, J.-L.; Virieux, D. Drug discovery: Phosphinolactone, in vivo bioisostere of the lactol group Org. Biomol. Chem. 2010, 8, 1438-1444
12. Chemical properties and reactions of phosphine chalcogenides. In The Chemistry of Organophosphorus Compounds; Hartley, F. R., Ed.; John Wiley & Sons: Chichester, 1992; Vol. 2, pp 287-408.
13. Hernández, J.; Ramos, R.; Sastre, N.; Meza, R.; Hommer, H.; Salas, M.; Gordillo, B. Conformational analysis of six-membered ring dioxaphosphinanes. Part 1: Anancomeric thiophosphates Tetrahedron 2004, 60, 10927-10941
14. Wadsworth, S.; Emmons, W. D. Bicyclic phosphites J. Am. Chem. Soc. 1962, 84, 610-617
15. Volle, J.-N.; Virieux, D.; Starck, M.; Monbrun, J.; Clarion, L.; Pirat, J.-L. Chiral phosphinyl analogues of 2-C-arylmorpholinols: 2-Aryl-3,5-diphenyl- [1,4,2]-oxazaphosphinanes Tetrahedron: Asymmetry 2006, 17, 1402-1408
16. McDonald, F. E.; Zhu, H. Y. H.; Holmquist, C. R. Rhodium-catalysed alkaline cyclotrimerization strategies for 6-arylglycoside synthesis J. Am. Chem. Soc. 1995, 117, 6605-6606
17. Harvey, T. C.; Simiand, C.; Weiler, L.; Withers, S. G. Synthesis of Cyclic Phosphonate Analogs of Ribose and arabinose J. Org. Chem. 1997, 62, 6722-6725
18. Hanessian, S.; Rogel, O. Synthesis of a phostone glycomimetic of the endothelin converting enzyme inhibitor phosphoramidon Bioorg. Med. Chem. Lett. 1999, 9, 2441-2446
19. Stoianova, D. S.; Whitehead, A.; Hanson, P. R. P-Heterocyclic Building Blocks: Application to the Stereoselective Synthesis of P-Sugars J. Org. Chem. 2005, 70, 5880-5889
20. Pirat, J.-L.; Virieux, D.; Volle, J.-N.; Clarion, L.; Bakalara, N.; Mersel, M.; Monbrun, J.; Cristau, H.-J. New phosphorus containing heterocyclic compounds, sugar analogs, and compositions having anticancer activity containing the same. PCT Int. Appl. WO 2009/004096 A1, 2009.
21. Volle, J.-N.; Filippini, D.; Midrier, C.; Virieux, D.; Pirat, J.-L.; Sobecki, M.; Drag, M. Revisited Synthesis of Aryl-H-phosphinates Synthesis 2011, 2490-2494
22. Cristau, H.-J.; Monbrun, J.; Schleiss, J.; Virieux, D.; Pirat, J.-L. First synthesis of P-aryl-phosphinosugars, organophosphorus analogues of C-arylglycosides Tetrahedron Lett. 2005, 46, 3741-3744
23. Filippini, D.; Loiseau, S.; Bakalara, N.; Dziuganowska, Z. A.; Van der Lee, A.; Volle, J.-N.; Virieux, D.; Pirat, J. L. Dramatic effect of modified boranes in diastereoselective reduction of chiral cyclic α- ketophosphinates RSC Adv. 2012, 2, 816-818
24. Cipolla, L.; Lay, L.; Nicotra, F.; Pangrazio, C.; Panza, L. Synthesis of Azasugars by Grignard Reaction on Glycosylamines Tetrahedron 1995, 51, 4679-4690
25. Behr, J. M.; Guillerm, G. Synthesis of 6-deoxy-homoDMDP and its C(5)-epimer: Absolute stereochemistry of natural products from Hyacinthus orientalis Tetrahedron: Asymmetry 2002, 13, 111-113
26. Stupp, R.; Mason, W. P.; Van den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma N. Engl. J. Med. 2005, 352, 987-996
27. Koziara, J. M.; Lockman, P. R.; Allen, D. D.; Mumper, R. J. Paclitaxel nanoparticles for the potential treatment of brain tumors J. Controlled Release 2004, 99, 259-269
28. Acton, E. M.; Narayanan, V. L.; Risbood, P. A.; Shoemaker, R. H.; Vistica, D. T.; Boyd, M. R. Anticancer specificity of some ellipticinium salts against human brain tumors in vitro J. Med. Chem. 1994, 37, 2185-2189
29. Scherf, U.; Ross, D. T.; Waltham, M.; Smith, L. H.; Lee, J. K.; Tanabe, L.; Kohn, K. W.; Reinhold, W. C.; Myers, T. G.; Andrews, D. T.; Scudiero, D. A.; Eisen, M. B.; Sausville, E. A.; Pommier, Y.; Botstein, D.; Brown, P. O.; Weinstein, J. N. A gene expression database for the molecular pharmacology of cancer Nat. Genet. 2000, 24, 236-244
30. Ross, D. T.; Scherf, U.; Eisen, M. B.; Perou, C. M.; Rees, C.; Spellman, P.; Iyer, V.; Jeffrey, S. S.; Van de Rijn, M.; Waltham, M.; Pergamenschikov, A.; Lee, J. C.; Lashkari, D.; Shalon, D.; Myers, T. G.; Weinstein, J. N.; Botstein, D.; Brown, P. O. Systematic variation in gene expression patterns in human cancer cell lines Nat. Genet. 2000, 24, 227-235
31. Blower, P. E.; Chung, J. H.; Verducci, J. S.; Lin, S.; Park, J. K.; Dai, Z.; Liu, C. G.; Schmittgen, T. D.; Reinhold, W. C.; Croce, C. M.; Weinstein, J. N.; Sadee, W. MicroRNAs modulate the chemosensitivity of tumor cells Mol. Cancer Ther. 2008, 7, 1-9
32. Blower, P. E.; Verducci, J. S.; Lin, S.; Zhou, J.; Chung, J. H.; Dai, Z.; Liu, C. G.; Reinhold, W.; Lorenzi, P. L.; Kaldjian, E. P.; Croce, C. M.; Weinstein, J. N.; Sadee, W. MicroRNA expression profiles for the NCI-60 cancer cell panel Mol. Cancer Ther. 2007, 6, 1483-1491
33. Lee, J. S.; Paull, K.; Alvarez, M.; Hose, C.; Monks, A.; Grever, M.; Fojo, A. T.; Bates, S. E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen Mol. Pharmacol. 1994, 46, 627-638
34. Rutka, J. T.; Giblin, J. R.; Dougherty, D. Y.; Liu, H. C.; McCulloch, J. R.; Bell, C. W.; Stern, R. S.; Wilson, C. B.; Rosenblum, M. L. Establishment and characterization of five cell lines derived from human malignant gliomas Acta Neuropathol. 1987, 75, 92-103
35. Audouy, S.; Mallet, J.; Privat, A.; Gimenez y Ribotta, M. Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis Glia 1999, 25, 293-303
36. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63
37. Repetto, G.; del Peso, A.; Zurita, J. L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity Nat. Protoc. 2008, 3, 1125-1131